Development Pipeline

Generics via ANDA &

Brands via 505(b)(2)

Jabez Applications

In seeking new and improved pharmaceutical products for both humans and animals, we have currently identified and begun development on 9 new drug products in our development pipeline.

Human Products

ANDA

Human Products

505(b)2

Animal Products

ANADA

Jabez Currently Has Nine Products in the Development Pipeline

We are currently working on four Abbreviated New Drug Application (ANDA), three 505(b)(2), and two Abbreviated New Animal Drug Applications (ANADAs).

Human

ANDA

C005

60%

C006

60%

C007

60%

C008

60%

505(b)2

S001

60%

S003

60%

S004

60%

Animal

ANADA

AH01

60%

AH02

40%